CRIS Current Research Information System

GRANITO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.091
AS - Asia 7.999
EU - Europa 7.135
AF - Africa 630
SA - Sud America 454
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.981
SG - Singapore 2.513
CN - Cina 2.486
IT - Italia 1.499
VN - Vietnam 1.457
GB - Regno Unito 1.413
DE - Germania 1.070
SE - Svezia 891
HK - Hong Kong 585
IN - India 410
RU - Federazione Russa 352
BR - Brasile 297
IE - Irlanda 283
UA - Ucraina 276
FR - Francia 250
NL - Olanda 250
KR - Corea 224
FI - Finlandia 216
TG - Togo 203
CH - Svizzera 166
ZA - Sudafrica 115
CI - Costa d'Avorio 113
SC - Seychelles 97
JP - Giappone 96
EE - Estonia 95
BG - Bulgaria 75
AR - Argentina 73
AT - Austria 69
CA - Canada 62
NG - Nigeria 46
PL - Polonia 41
JO - Giordania 40
BE - Belgio 38
ID - Indonesia 36
MX - Messico 36
EC - Ecuador 28
TR - Turchia 28
ES - Italia 27
PK - Pakistan 22
GR - Grecia 21
HR - Croazia 21
BD - Bangladesh 19
RO - Romania 16
LT - Lituania 15
EG - Egitto 14
IQ - Iraq 14
IR - Iran 13
AU - Australia 12
CL - Cile 12
CO - Colombia 12
MA - Marocco 11
VE - Venezuela 11
CZ - Repubblica Ceca 10
TW - Taiwan 9
MK - Macedonia 8
PT - Portogallo 8
PY - Paraguay 8
SA - Arabia Saudita 8
NZ - Nuova Zelanda 7
TN - Tunisia 7
DZ - Algeria 6
KE - Kenya 6
MY - Malesia 6
RS - Serbia 6
AL - Albania 5
AZ - Azerbaigian 5
PE - Perù 5
PH - Filippine 5
UY - Uruguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
LB - Libano 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
IL - Israele 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
DJ - Gibuti 1
DM - Dominica 1
ET - Etiopia 1
GL - Groenlandia 1
HN - Honduras 1
MD - Moldavia 1
MR - Mauritania 1
Totale 26.323
Salva come PNG Salva come JPEG
Città #
Singapore 1.647
Southend 1.233
Ashburn 1.202
Fairfield 1.021
Chandler 875
Dong Ket 688
Hong Kong 575
Hefei 540
Woodbridge 490
Santa Clara 465
Houston 450
Seattle 445
Wilmington 429
Cambridge 341
Princeton 339
Bologna 319
Beijing 313
Dublin 282
Ann Arbor 261
Boardman 249
Seoul 221
Lomé 203
Ho Chi Minh City 181
Helsinki 170
Jacksonville 166
Hanoi 158
Munich 156
Bern 152
Los Angeles 138
Dallas 128
San Jose 127
Berlin 122
Nanjing 121
Westminster 119
Milan 114
Abidjan 113
New York 112
Padova 109
Frankfurt am Main 94
Tokyo 86
Buffalo 80
Jinan 77
Shenyang 77
Rome 75
Redondo Beach 73
Sofia 71
San Diego 61
Saint Petersburg 59
Turin 58
Bremen 57
Guangzhou 57
Des Moines 54
Changsha 51
Bengaluru 48
Vienna 44
Abeokuta 43
Nanchang 42
Amman 40
Phoenix 39
Mülheim 38
Brussels 37
Falkenstein 37
Hebei 37
Shanghai 37
Chicago 34
Redmond 34
Tianjin 32
Nuremberg 31
São Paulo 31
Medford 30
Orem 28
Warsaw 28
Florence 27
Hangzhou 27
London 27
Ningbo 26
Yubileyny 25
Olalla 24
Washington 24
Chengdu 22
Dearborn 22
Falls Church 22
Haiphong 22
Moscow 22
Turku 22
Haikou 21
Jakarta 21
Lappeenranta 21
Wuhan 21
Zhengzhou 21
Amsterdam 20
Jiaxing 20
Bühl 19
Redwood City 19
Taiyuan 19
Da Nang 18
Düsseldorf 18
Verona 18
Brooklyn 17
Denver 17
Totale 17.096
Salva come PNG Salva come JPEG
Nome #
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 312
Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods 282
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 280
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 251
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 232
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 229
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 226
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 223
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 221
Clinical and serological profile of primary biliary cirrhosis in men. 218
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 210
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 209
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 208
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 206
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 204
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 199
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 199
Antinuclear antibodies in COVID 19 199
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 197
Anti-actin IgA antibodies in severe coeliac disease 194
Autoimmune enteropathy and rheumatoid arthritis: A new association in the field of autoimmunity. 193
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 192
Monofocal hepatocellular carcinoma: How much does size matter? 190
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 189
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? 186
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 184
A case of leptospirosis simulating colon cancer with liver metastases 182
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 176
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 175
Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis 174
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 170
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 169
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 169
Current guidelines for the management of celiac disease: A systematic review with comparative analysis 168
Diagnosis and therapy of autoimmune hepatitis. 168
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 168
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 167
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 166
Autoimmune liver disease 2007. 165
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 165
Metabolic disorders across hepatocellular carcinoma in Italy 165
null 164
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 163
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 162
Pattern of macrovascular invasion in hepatocellular carcinoma 162
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 161
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 161
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 157
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 157
Autoimmune hepatitis in Italy: the Bologna experience. 157
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 157
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: A multicenter real-life study 157
Sensorineural hearing loss and celiac disease: a coincidental finding 156
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 156
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 156
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 156
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 153
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 152
Specific antinuclear reactivities in primary biliary cirrhosis 151
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors 151
Deamidated gliadin Peptide antibodies as a routine test for celiac disease: a prospective analysis. 150
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. 149
Antitransglutaminase antibodies and giardiasis 149
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. 149
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib 149
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 148
Antibodies to gangliosides in coeliac disease with neurological manifestations. 147
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 146
PO.8 COELIAC DISEASE MISDIAGNOSIS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY 145
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers 144
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 144
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 142
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 142
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 142
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 142
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 141
COVID-19: Has the Liver Been Spared? 141
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 140
Diagnostic accuracy of different patterns of contrast enhanced ultrasound in characterization of new nodules in liver cirrhosis with and without history of previous hepatocellular carcinoma. 138
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives 137
Celiac disease in autoimmune cholestatic liver disorders 136
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study 135
HCV and autoimmunity. 134
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients? 133
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib 132
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 132
Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program 132
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 130
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. 130
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 130
Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. 130
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 129
Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro. 128
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin 128
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease 126
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments 125
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 124
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 124
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. 123
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 123
Totale 16.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.705 0 0 0 0 0 0 47 154 223 127 103 1.051
2021/20223.341 237 60 204 251 259 169 81 237 131 263 927 522
2022/20233.827 411 503 188 492 255 315 198 182 615 132 274 262
2023/20241.307 76 182 95 116 115 245 70 126 59 72 89 62
2024/20254.983 223 556 554 354 693 301 466 200 121 362 264 889
2025/20266.066 990 1.125 1.009 840 1.226 624 252 0 0 0 0 0
Totale 26.860